Healthtech Startups
16,890 companies tagged Healthtech, with their investors and founders.
Nimbus acquires and consolidates pulmonary care practices across the United States, unifying them under standardized clinical protocols and connecting patients to care through its own technology platform. The company serves patients with chronic respiratory conditions including COPD, fibrotic interstitial lung disease, sleep apnea, and asthma.
3 investors
Nira Medical consolidates independent neurology practices across the United States to improve patient access to neurological care. The company operates as a provider network focused on outpatient brain and neurological disorder treatment for patients seeking specialized care.
3 investors
Niramai develops an AI-based, radiation-free thermal imaging medical device (Thermalytix, SMILE-100, and Mythri) for early detection of breast cancer, offering a low-cost, portable, non-invasive screening tool for use in clinics, hospitals, and outreach camps. The technology serves healthcare providers screening women across a wide age range and is deployed in over 22 countries.
3 investors
Nivati is an employee mental health and wellbeing platform that combines an AI-powered companion app with access to licensed therapists, dietitians, financial coaches, group workshops, self-guided content, and 24/7 call and chat therapy. It is sold to employers as a replacement for traditional EAP services, with analytics and ROI tools for HR teams.
3 investors
Nkarta is a biotech company developing allogeneic CAR NK cell therapies for autoimmune diseases, aiming to offer safer and more accessible alternatives to autologous CAR-T treatments. Its lead program, NKX019, targets the CD19 antigen for B cell-mediated autoimmune conditions such as lupus nephritis and systemic sclerosis.
3 investors
NK:IO develops natural killer (NK) cell and small molecule therapies for cancer, targeting both haematological and solid tumours such as ovarian cancer. Its platform technologies, based on umbilical cord blood stem cells, aim to expand NK cells and enhance their tumour-killing capacity for cancer immunotherapy, with programmes at the research and early preclinical stage.
3 investors
Noat is a vertically integrated nicotine products company that develops and manufactures harm-reduction alternatives to tobacco using natural, food-grade ingredients and sustainable materials. The company targets adult nicotine users with discreet, transparent products designed to minimize health risks while eliminating environmental waste.
3 investors
Nolia Health provides support for family caregivers of people with memory loss or chronic conditions, offering therapy, day-to-day care guidance, and medical evaluations such as memory testing through an interdisciplinary care team. Most services are covered by Medicare and many insurance plans, and the company serves patients in California and Washington.
3 investors
Norbert Health develops multimodal sensing AI and autonomous care technology for healthcare facilities, combining hardware and machine learning to monitor patients and reduce clinical workload. The company builds investigational medical devices validated to clinical standards for use in care settings.
3 investors
Norstella is a global pharma intelligence provider that unites companies including Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group to supply data, advisory services, and analytics for strategic and commercial decision-making in the pharmaceutical industry. It serves pharma clients working to bring therapies to market.
3 investors
NorthSea Therapeutics is a late-stage clinical biotechnology company developing structurally engineered fatty acids (SEFAs) as oral treatments for metabolic, cholestatic, and fibrotic diseases. Its pipeline targets conditions such as intestinal failure-associated liver disease, severe hypertriglyceridemia, and metabolic dysfunction-associated steatohepatitis.
3 investors
Novadip develops regenerative medicine treatments using its 3M3 tissue regeneration platform to address conditions requiring bone and tissue repair, including spinal fusion, cancer recovery, and complex fractures.
3 investors
NovaScan develops a platform technology combining AI and spectral bioimpedance for oncology applications, with multiple diagnostic and intraoperative products built on a shared hardware and software foundation currently in clinical trials.
3 investors
NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.
3 investors
Quince Therapeutics is a clinical-stage biopharmaceutical company developing eDSP, an investigational therapy studied in a Phase 3 clinical trial (NEAT) for patients with Ataxia-Telangiectasia (A-T). The company focuses on treatments for rare and debilitating diseases.
3 investors
NOWDiagnostics develops rapid, point-of-care and consumer diagnostic tests. The company operates in the medical diagnostics and MedTech industry.
3 investors
Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection. It serves the medical diagnostics and biotechnology market.
3 investors
Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases. The company leverages innovative cell biology and gene therapy technologies to address genetic and acquired cardiac conditions.
3 investors
Numen develops at-home cancer diagnostics and health data collection infrastructure using machine learning models to enable earlier intervention and improve patient outcomes.
3 investors
Nura Bio develops neuroprotective medicines targeting neurological diseases by translating scientific advances in axonal degeneration and neuroimmune regulation into novel therapeutics.
3 investors
Nursa operates a marketplace platform that connects healthcare facilities with nurses and nursing assistants to fill per diem shifts on demand.
3 investors
Nurx provides online specialty healthcare for women, offering telehealth consultations, prescription medications, and treatment options for sexual, reproductive, and mental health concerns with free shipping and home delivery.
3 investors
Nutromics is developing a wearable patch for continuous, real-time monitoring of biomarkers in hospital settings, starting with therapeutic drug monitoring of the antibiotic vancomycin. The technology aims to help clinicians keep patients within the therapeutic range and is intended to expand into infectious disease, cardiology, and renal indications.
3 investors
Nuwellis develops medical technology solutions for managing fluid overload in patients with cardiorenal conditions, serving clinicians and healthcare providers in inpatient and outpatient settings. The company focuses on treating the interconnection between heart and kidney function to improve patient outcomes and accelerate recovery.
3 investors